Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Consortium for detection and management of lung damage induced by bleomycin].
Biya J, Stoclin A, Dury S, Le Pavec J, Mir O, Lazarovici J, Fermé C, Annereau M, Ekpe K, Massard C, Michot JM. Biya J, et al. Among authors: annereau m. Bull Cancer. 2016 Jul-Aug;103(7-8):651-61. doi: 10.1016/j.bulcan.2016.04.005. Epub 2016 May 27. Bull Cancer. 2016. PMID: 27241272 Review. French.
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.
Michot JM, Fusellier M, Champiat S, Velter C, Baldini C, Voisin AL, Danlos FX, Dakdouki YE, Annereau M, Mariette X, Robert C, Cherif K, Marabelle A, Mateus C, Lambotte O. Michot JM, et al. Among authors: annereau m. Ann Rheum Dis. 2019 Jul;78(7):e67. doi: 10.1136/annrheumdis-2018-213677. Epub 2018 Jun 1. Ann Rheum Dis. 2019. PMID: 29858173 No abstract available.
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result.
Michot JM, Annereau M, Danu A, Legoupil C, Bertin L, Chahine C, Achab N, Antosikova A, Cerutti A, Rossignol J, Ghez D, Willekens C, Dartigues P, Lazarovici J, Lemare F, Ribrag V. Michot JM, et al. Among authors: annereau m. Eur J Haematol. 2020 Apr;104(4):281-290. doi: 10.1111/ejh.13369. Epub 2020 Jan 28. Eur J Haematol. 2020. PMID: 31838764 Clinical Trial.
Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma.
Michot JM, Buet-Elfassy A, Annereau M, Lazarovici J, Danu A, Sarkozy C, Chahine C, Bigenwald C, Bosq J, Rossignol J, Romano-Martin P, Baldini C, Ghez D, Dartigues P, Massard C, Ribrag V. Michot JM, et al. Among authors: annereau m. Cancer Drug Resist. 2021 Mar 26;4(3):710-718. doi: 10.20517/cdr.2020.109. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582306 Free PMC article.
Aprepitant for paediatric chemotherapy-induced nausea and vomiting.
Slimano F, Rigaud C, Annereau M, Gaspar N, Lemare F. Slimano F, et al. Among authors: annereau m. Lancet Oncol. 2015 Jun;16(6):e259. doi: 10.1016/S1470-2045(15)70205-6. Epub 2015 May 27. Lancet Oncol. 2015. PMID: 26065607 No abstract available.
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
Roy P, Canet-Jourdan C, Annereau M, Zajac O, Gelli M, Broutin S, Mercier L, Paci A, Lemare F, Ducreux M, Elias D, Malka D, Boige V, Goéré D, Jaulin F. Roy P, et al. Among authors: annereau m. Int J Pharm. 2017 Oct 5;531(1):143-152. doi: 10.1016/j.ijpharm.2017.07.084. Epub 2017 Aug 11. Int J Pharm. 2017. PMID: 28803938
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
Cartry J, Bedja S, Boilève A, Mathieu JRR, Gontran E, Annereau M, Job B, Mouawia A, Mathias P, De Baère T, Italiano A, Besse B, Sourrouille I, Gelli M, Bani MA, Dartigues P, Hollebecque A, Smolenschi C, Ducreux M, Malka D, Jaulin F. Cartry J, et al. Among authors: annereau m. J Exp Clin Cancer Res. 2023 Oct 25;42(1):281. doi: 10.1186/s13046-023-02853-4. J Exp Clin Cancer Res. 2023. PMID: 37880806 Free PMC article.
34 results